Drug Shortage Report for TOBRAMYCIN INHALATION SOLUTION

Last updated on 2021-09-14 History
Report ID 145010
Drug Identification Number 02443368
Brand name TOBRAMYCIN INHALATION SOLUTION
Common or Proper name TOBRAMYCIN INH
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 300MG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging size 56 LIN
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-08-30
Estimated end date Unknown
Actual end date 2021-08-08
Shortage status Avoided shortage
Updated date 2021-09-14
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-09-14 English Compare
v4 2021-09-02 French Compare
v3 2021-09-02 English Compare
v2 2021-09-02 French Compare
v1 2021-09-02 English Compare